Jundishapur Journal of Microbiology

Published by: Kowsar

Human T- Lymphotropic Virus Type 1 in Blood Donors from Babol County Blood Transfusion Center: A Pilot Study From Northern Iran

Yousef Yahyapour 1 , Kazem Aghajanipour 2 , Seyed Mostafa Mir 3 , Aynaz Khademian 4 and Farzin Sadeghi 5 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran
2 Babol County Blood Transfusion Center, Babol, Iran
3 Department of Clinical Biochemistry, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
4 Department of Microbiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
5 Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Article information
  • Jundishapur Journal of Microbiology: September 2017, 10 (9); e13757
  • Published Online: September 2, 2017
  • Article Type: Research Article
  • Received: March 3, 2017
  • Revised: May 21, 2017
  • Accepted: June 24, 2017
  • DOI: 10.5812/jjm.13757

To Cite: Yahyapour Y, Aghajanipour K, Mir S M, Khademian A, Sadeghi F. Human T- Lymphotropic Virus Type 1 in Blood Donors from Babol County Blood Transfusion Center: A Pilot Study From Northern Iran, Jundishapur J Microbiol. 2017 ; 10(9):e13757. doi: 10.5812/jjm.13757.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016; 4(9)-16[DOI][PubMed]
  • 2. Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012; 3: 388[DOI][PubMed]
  • 3. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39): 6058-68[DOI][PubMed]
  • 4. Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010; 23(3): 577-89[DOI][PubMed]
  • 5. Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, et al. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009. J Infect Dis. 2014; 209(4): 523-31[DOI][PubMed]
  • 6. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
  • 7. Hedayati-Moghaddam MR, Tehranian F, Bayati M. Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors. Viruses. 2015; 7(11): 5736-45[DOI][PubMed]
  • 8. Hedayati-Moghaddam MR. A Systematic Review for Estimation of HTLV-I Infection in the Blood Donors of Iran. Iran J Basic Med Sci. 2013; 16(3): 196-201[PubMed]
  • 9. Sadeghi F, Bokharaei-Salim F, Salehi-Vaziri M, Monavari SH, Alavian SM, Salimi S, et al. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNalpha-2a and ribavirin in Iranian patients with chronic hepatitis C. J Med Virol. 2014; 86(9): 1499-506[DOI][PubMed]
  • 10. Salehi-Vaziri M, Sadeghi F, Alamsi-Hashiani A, Haeri H, Monavari SH, Keyvani H. Merkel cell polyomavirus and human papillomavirus infections in cervical disease in Iranian women. Arch Virol. 2015; 160(5): 1181-7[DOI][PubMed]
  • 11. Naderi M, Paryan M, Azadmanesh K, Rafatpanah H, Rezvan H, Mirab Samiee S. Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood. J Clin Virol. 2012; 53(4): 302-7[DOI][PubMed]
  • 12. Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J. 2011; 13(6): 424-7[PubMed]
  • 13. Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012; 28(9): 1095-101[DOI][PubMed]
  • 14. Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008; 19(5): 838-41[PubMed]
  • 15. Rafatpanah H, Torkamani M, Valizadeh N, Vakili R, Meshkani B, Khademi H, et al. Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran. J Med Virol. 2016; 88(7): 1247-53[DOI][PubMed]
  • 16. Ajami A, Hosseini RF, Tabarestani N. Seroepidemiological survey of HTLV-I/II in blood donors of Mazandaran in 1999 [In Persian]. J Mazandaran Univ Med Sci. 2000; 10(26): 45-8
  • 17. Ghaffari J, Kowsarian M, Mahdavi M, Vahid Shahi K, Rafatpanah H, Tafreshian A. Prevalence of HTLV-I infection in patients with thalassemia major in Mazandaran, North of Iran. Jundishapur J Microbiol. 2012; 6(1): 57-60[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments